Malignant gliomas: strategies to increase the effectiveness of targeted molecular treatment
作者： Patrick Y Wen , Santosh Kesari , Jan Drappatz
关键词:
摘要: Recently, there has been increasing interest in the use of targeted molecular agents for treatment malignant gliomas. These are generally well tolerated but have demonstrated only modest activity. In this article, current status gliomas will be reviewed and strategies to improve their effectiveness discussed.
expert-reviews.com参考文章(181)
Syed R. Husain, Raj K. Puri, Interleukin-13 receptor-directed cytotoxin for malignant glioma therapy: from bench to bedside. Journal of Neuro-oncology. ,vol. 65, pp. 37- 48 ,(2003) , 10.1023/A:1026242432647
Katrin Lamszus, Oliver Heese, Manfred Westphal, Angiogenesis-related growth factors in brain tumors. Cancer treatment and research. ,vol. 117, pp. 169- 190 ,(2004) , 10.1007/978-1-4419-8871-3_12
Ariane Söling, Nikolai G Rainov, Technology evaluation: TransMID, KS Biomedix/Nycomed/Sosei/PharmaEngine. Current Opinion in Molecular Therapeutics. ,vol. 7, pp. 483- ,(2005)
Grace K. Dy, Alex A. Adjei, Obtacles and opportunities in the clinical development of targeted therapeutics Progress in drug research. ,vol. 63, pp. 19- 41 ,(2005) , 10.1007/3-7643-7414-4_2
C David James, Genetic and signaling pathway alterations in glioblastoma relevance to novel targeted therapies Frontiers in Bioscience. ,vol. 8, pp. e270- 280 ,(2003) , 10.2741/897
A Boddy, R Plummer, R Dewji, H Calvert, M Middleton, H Newell, C Jones, N Curtin, A Harris, R Kaufman, J Evans, L Robson, R Wilson, P Johnston, A Olson, Final clinical, pharmacokinetic and pharmacodynamic results of the phase I study of the novel poly(ADP-ribose)polymerase (PARP) inhibitor, AG014699, in combination with temozolomide Clinical Cancer Research. ,vol. 11, ,(2005)
Mariko Kawakami, Koji Kawakami, Raj K. Puri, Interleukin-4-Pseudomonas exotoxin chimeric fusion protein for malignant glioma therapy. Journal of Neuro-oncology. ,vol. 65, pp. 15- 25 ,(2003) , 10.1023/A:1026294416718
Adrian M. Senderowicz, Inhibitors of cyclin-dependent kinase modulators for cancer therapy Progress in drug research. ,vol. 63, pp. 183- 206 ,(2005) , 10.1007/3-7643-7414-4_8
Kyle D. Weaver, Susan Yeyeodu, James C. Cusack, Jr., Albert S. Baldwin, Jr., Matthew G. Ewend, Potentiation of chemotherapeutic agents following antagonism of nuclear factor kappa B in human gliomas Journal of Neuro-oncology. ,vol. 61, pp. 187- 196 ,(2003) , 10.1023/A:1022554824129
John H. Sampson, Gamal Akabani, Gary E. Archer, Darell D. Bigner, Mitchel S. Berger, Allan H. Friedman, Henry S. Friedman, James E. Herndon II, Sandeep Kunwar, Steve Marcus, Roger E. McLendon, Alison Paolino, Kara Penne, James Provenzale, Jennifer Quinn, David A. Reardon, Jeremy Rich, Timothy Stenzel, Sandra Tourt-Uhlig, Carol Wikstrand, Terence Wong, Roger Williams, Fan Yuan, Michael R. Zalutsky, Ira Pastan, Progress Report of a Phase I Study of the Intracerebral Microinfusion of a Recombinant Chimeric Protein Composed of Transforming Growth Factor (TGF)-α and a Mutated form of the Pseudomonas Exotoxin Termed PE-38 (TP-38) for the Treatment of Malignant Brain Tumors Journal of Neuro-oncology. ,vol. 65, pp. 27- 35 ,(2003) , 10.1023/A:1026290315809